Vaccines and clots:
Please see the link below for the full text
Over 34 million people have received a first dose so far. The vaccine programme is estimated to have prevented over 10,000 deaths by the end of March.
Adverse events following the Oxford/AstraZeneca vaccine are extremely rare and, for the vast majority of people, the benefits of preventing serious illness and death far outweigh any risks.
The current situation is
Everybody who has already had a first dose of the Oxford/AstraZeneca vaccine should receive a second dose of the same jab, irrespective of age, except for the very small number of people who experienced blood clots with low platelet counts from their first vaccination.
Getting the second vaccine dose is very important because it further increases the level of protection against COVID-19.
As a precautionary measure, anyone who has the following symptoms from around 4 days to 4 weeks after vaccination is advised to seek prompt medical advice:
a severe headache that is not relieved with painkillers or is getting worse
a headache that feels worse when you lie down or bend over
a headache that is unusual for you and occurs with blurred vision, feeling or being sick, problems speaking, weakness, drowsiness or seizures
a rash that looks like small bruises or bleeding under the skin
shortness of breath, chest pain, leg swelling or persistent abdominal pain
Under 40s will be offered an alternative to Astra Zeneca